Sehat Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-10-2024
- Paid Up Capital ₹ 1.00 M
as on 29-10-2024
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
as on 29-10-2024
- Satisfied Charges ₹ 1.60 M
as on 29-10-2024
- Revenue -8.59%
(FY 2023)
- Profit -33.53%
(FY 2023)
- Ebitda -1.69%
(FY 2023)
- Net Worth 14.28%
(FY 2023)
- Total Assets 17.54%
(FY 2023)
About Sehat Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.50 M. The company has closed loans amounting to ₹1.60 M, as per Ministry of Corporate Affairs (MCA) records.
Makbulhusen Lala and Mohmedishhak Lala serve as directors at the Company.
- CIN/LLPIN
U24231GJ1995PTC025492
- Company No.
025492
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Sabarkantha, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sehat Pharma Pvt Ltd offer?
Sehat Pharma Pvt Ltd offers a wide range of products and services, including Skin Creams, Neomycin Cream, Antipyretic Medication, Paracetamol Tablets, Veterinary Medicines, Veterinary Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Team Sports Goods & Supplies, Sports Balls.
Who are the key members and board of directors at Sehat Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Makbulhusen Lala  | Director | 01-Mar-2001 | Current |
| Mohmedishhak Lala | Director | 01-Mar-2001 | Current |
Financial Performance of Sehat Pharma.
Sehat Pharma Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.59% decrease. The company also saw a substantial fall in profitability, with a 33.53% decrease in profit. The company's net worth Soared by an impressive increase of 14.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sehat Pharma?
Unlock access to Sehat Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Sarvodaya Nagrik Sahkari Bank Ltd. Creation Date: 24 Nov 2012 | ₹0.50 M | Open |
Bank Of Baroda Creation Date: 12 Jul 2006 | ₹1.60 M | Satisfied |
State Bank Of India Creation Date: 01 May 1996 | - | Satisfied |
How Many Employees Work at Sehat Pharma?
Unlock and access historical data on people associated with Sehat Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sehat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sehat Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
